Health
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store – Yahoo News Australia
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from…
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full-strength doses were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full-strength dose to follow — that one was 90% effective.
Oxford’s results may not have…
-
General14 hours agoPublisher ditches David Walliams after harassment claim
-
General13 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General12 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
Business9 hours agoThe ETF portfolio I’d build if I never wanted to watch markets again